243 related articles for article (PubMed ID: 34334059)
1. Current treatment of recurrent pericarditis: safety considerations and future directions.
Imazio M
Expert Opin Drug Saf; 2022 Feb; 21(2):183-190. PubMed ID: 34334059
[TBL] [Abstract][Full Text] [Related]
2. Advances in medical therapy for pericardial diseases.
Galluzzo A; Imazio M
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):635-643. PubMed ID: 30103638
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Pericarditis: Modern Approach in 2016.
Imazio M; Adler Y; Charron P
Curr Cardiol Rep; 2016 Jun; 18(6):50. PubMed ID: 27108360
[TBL] [Abstract][Full Text] [Related]
4. New Developments in the Management of Recurrent Pericarditis.
Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V
Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863
[TBL] [Abstract][Full Text] [Related]
5. Advances in pharmacotherapy for acute and recurrent pericarditis.
Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
[TBL] [Abstract][Full Text] [Related]
6. Clinical Trials in Pericardial Disease: New Paradigm Shift.
Imazio M
Curr Cardiol Rep; 2021 Oct; 23(11):170. PubMed ID: 34633515
[TBL] [Abstract][Full Text] [Related]
7. Recurrent pericarditis: new and emerging therapeutic options.
Imazio M; Lazaros G; Brucato A; Gaita F
Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatment of acute and recurrent pericarditis: a systematic review and meta-analysis of controlled clinical trials.
Avondo S; Andreis A; Casula M; Biondi-Zoccai G; Imazio M
Panminerva Med; 2021 Sep; 63(3):314-323. PubMed ID: 34738773
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
[TBL] [Abstract][Full Text] [Related]
10. Colchicine for the prevention of recurrent pericarditis.
Markel G; Imazio M; Brucato A; Adler Y
Isr Med Assoc J; 2008 Jan; 10(1):69-72. PubMed ID: 18300579
[TBL] [Abstract][Full Text] [Related]
11. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
[TBL] [Abstract][Full Text] [Related]
12. Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins.
Orabona R; Zanardini C; Zatti S; Lojacono A; Procopio R; Vizzardi E; Tincani A; Sartori E; Andreoli L
J Cardiovasc Med (Hagerstown); 2020 May; 21(5):393-395. PubMed ID: 32040030
[No Abstract] [Full Text] [Related]
13. Prevention of recurrent pericarditis with colchicine in 2012.
Markel G; Imazio M; Brucato A; Adler Y
Clin Cardiol; 2013 Mar; 36(3):125-8. PubMed ID: 23404655
[TBL] [Abstract][Full Text] [Related]
14. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pericarditis.
Imazio M; Battaglia A; Gaido L; Gaita F
Rev Med Interne; 2017 May; 38(5):307-311. PubMed ID: 28185680
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis.
Melendo-Viu M; Marchán-Lopez Á; Guarch CJ; Roubín SR; Abu-Assi E; Meneses RT; Ynsaurriaga FA; Hernandez AV; Bueno H
Trends Cardiovasc Med; 2023 Jul; 33(5):319-326. PubMed ID: 35131416
[TBL] [Abstract][Full Text] [Related]
17. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.
Gupta M; Kaul S; Velazquez GR; Bandyopadhyay D; Fonarow GC; Klein A; Ghosh RK
Am J Cardiovasc Drugs; 2022 Jan; 22(1):27-33. PubMed ID: 34008144
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis.
Peiffer-Smadja N; Domont F; Saadoun D; Cacoub P
Autoimmun Rev; 2019 Jun; 18(6):621-626. PubMed ID: 30959210
[TBL] [Abstract][Full Text] [Related]
19. RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.
Klein AL; Imazio M; Brucato A; Cremer P; LeWinter M; Abbate A; Lin D; Martini A; Beutler A; Chang S; Fang F; Gervais A; Perrin R; Paolini JF
Am Heart J; 2020 Oct; 228():81-90. PubMed ID: 32866928
[TBL] [Abstract][Full Text] [Related]
20. Acute recurrent pericarditis: from pathophysiology towards new treatment strategy.
Cacoub P; Marques C
Heart; 2020 Jul; 106(14):1046-1051. PubMed ID: 32238419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
